106 related articles for article (PubMed ID: 1998848)
1. Double-blind randomized trial of perioperative fibrinolytic enhancement for femoropopliteal bypass.
Berridge DC; Frier M; Westby JC; Hopkinson BR; Makin GS
Br J Surg; 1991 Jan; 78(1):101-4. PubMed ID: 1998848
[TBL] [Abstract][Full Text] [Related]
2. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery.
Blamey SL; McArdle BM; Burns P; Carter DC; Lowe GD; Forbes CD
Thromb Haemost; 1984 Feb; 51(1):71-4. PubMed ID: 6539002
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
[TBL] [Abstract][Full Text] [Related]
4. Defective fibrinolysis occurs after infrainguinal reconstruction.
Killewich LA; Macko RF; Gardner AW; Cox K; Lilly MP; Flinn WR
J Vasc Surg; 1997 May; 25(5):858-64; discussion 865. PubMed ID: 9152313
[TBL] [Abstract][Full Text] [Related]
5. Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?
Goldman M; Hall C; Dykes J; Hawker RJ; McCollum CN
Br J Surg; 1983 Oct; 70(10):635-8. PubMed ID: 6414571
[TBL] [Abstract][Full Text] [Related]
6. Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.
Blamey SL; McArdle BM; Burns P; Lowe GD; Forbes CD; Carter DC; Prentice CR
Thromb Res; 1983 Aug; 31(3):451-9. PubMed ID: 20218001
[TBL] [Abstract][Full Text] [Related]
7. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.
Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD
Q J Med; 1986 Jan; 58(225):19-27. PubMed ID: 3517926
[TBL] [Abstract][Full Text] [Related]
8. Platelet inhibitory drugs: an in vivo method of evaluation in patients.
Norcott HC; Goldman M; Hawker RJ; Rafiqi EI; Drolc Z; McCollum CN
Thromb Haemost; 1982 Dec; 48(3):307-10. PubMed ID: 6761890
[TBL] [Abstract][Full Text] [Related]
9. The effect of fibrinolytic stimulation by stanozolol on postoperative pulmonary complications.
Cuschieri RJ; Morran CG; Lowe GD; Blamey SL; Forbes CD; McArdle CS
Haemostasis; 1985; 15(5):353-6. PubMed ID: 4076841
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic enhancement with stanozolol fails to improve symptoms and signs in patients with post-surgical back pain.
Cooper RG; Mitchell WS; Illingworth KJ; Jayson MI
Scand J Rheumatol; 1991; 20(6):414-8. PubMed ID: 1837614
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency.
Winter JH; Fenech A; Bennett B; Douglas AS
Br J Haematol; 1984 Jul; 57(3):527-37. PubMed ID: 6743570
[TBL] [Abstract][Full Text] [Related]
12. Decreased plasma fibrinolysis in patients with rheumatoid arthritis.
Belch JJ; McArdle B; Madhok R; McLaughlin K; Capell HA; Forbes CD; Sturrock RD
Ann Rheum Dis; 1984 Dec; 43(6):774-7. PubMed ID: 6084477
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic enhancement by stanozolol: a double blind trial.
Davidson JF; Lochhead M; McDonald GA; McNicol GP
Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
[No Abstract] [Full Text] [Related]
14. Treatment with stanozolol before thrombolysis in patients with arterial occlusions.
Noll G; Lämmle B; Duckert F
Thromb Res; 1985 Feb; 37(4):529-32. PubMed ID: 3983908
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
Goldman MD; Simpson D; Hawker RJ; Norcott HC; McCollum CN
Ann Surg; 1983 Dec; 198(6):713-6. PubMed ID: 6227296
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R
J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387
[TBL] [Abstract][Full Text] [Related]
17. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
[TBL] [Abstract][Full Text] [Related]
18. Femoropopliteal bypass grafts--an isotope technique allowing in vivo comparison of thrombogenicity.
Goldman M; Norcott HC; Hawker RJ; Hail C; Drolc Z; McCollum CN
Br J Surg; 1982 Jul; 69(7):380-2. PubMed ID: 6213283
[TBL] [Abstract][Full Text] [Related]
19. Perioperative complications of in-situ vein bypass.
Gannon MX; Goldman MD; Simms MH; Ruddock S; Ashton F; Slaney G
Ann R Coll Surg Engl; 1986 May; 68(3):134-6. PubMed ID: 3729260
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
